EUVIMEDEUVIMED entdecken
Video/Audio

Translational Orthotopic Models of Glioblastoma Multiforme

Rajaa El Meskini, Devon Atkinson, Zoë Weaver Ohler

Journal of Visualized Experiments · 2023

DOI: 10.3791/64482 ↗

Kurz gefasst

Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2023. Verfasst von Rajaa El Meskini und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Transplants, Glioma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetically engineered mouse (GEM) models for human glioblastoma multiforme (GBM) are critical to understanding the development and progression of brain tumors. Unlike xenograft tumors, in GEMs, tumors arise in the native microenvironment in an immunocompetent mouse. However, the use of GBM GEMs in preclinical treatment studies is challenging due to long tumor latencies, heterogeneity in neoplasm frequency, and the timing of advanced grade tumor development. Mice induced via intracranial orthotopic injection are more tractable for preclinical studies, and retain features of the GEM tumors. We generated an orthotopic brain tumor model derived from a GEM model with Rb, Kras, and p53 aberrations (TRP), which develops GBM tumors displaying linear foci of necrosis by neoplastic cells, and dense vascularization analogous to human GBM. Cells derived from GEM GBM tumors are injected intracranially into wild-type, strain-matched recipient mice and reproduce grade IV tumors, therefore bypassing the long tumor latency period in GEM mice and allowing for the creation of large and reproducible cohorts for preclinical studies. The highly proliferative, invasive, and vascular features of the TRP GEM model for GBM are recapitulated in the orthotopic tumors, and histopathology markers reflect human GBM subgroups. Tumor growth is monitored by serial MRI scans. Due to the invasive nature of the intracranial tumors in immunocompetent models, carefully following the injection procedure outlined here is essential to prevent extracranial tumor growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsTransplantsGliomaHumansAnimalsMiceBrainTumor Microenvironment

Autor:innen und Institutionen

  • Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute.
  • Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute; zweaverohler@mail.nih.gov.

Förderung

  • NCI NIH HHS

Zitieren

APA

El Meskini, R., Atkinson, D., & Weaver Ohler, Z. (2023). Translational Orthotopic Models of Glioblastoma Multiforme. Journal of Visualized Experiments. https://doi.org/10.3791/64482

Vancouver

El Meskini R, Atkinson D, Weaver Ohler Z. Translational Orthotopic Models of Glioblastoma Multiforme. Journal of Visualized Experiments. 2023. doi:10.3791/64482

BibTeX
@article{ElMeskini2023,
  author = {El Meskini, Rajaa and Atkinson, Devon and Weaver Ohler, Zoë},
  title = {Translational Orthotopic Models of Glioblastoma Multiforme},
  journal = {Journal of Visualized Experiments},
  year = {2023},
  doi = {10.3791/64482}
}
Kostenlos starten →